Allogenic umbilical cord-derived mesenchymal stem cell therapy (Nanjing University)

N/A

Report date: 2024/08/01 20:00:04

Base Information

Drug NameAllogenic umbilical cord-derived mesenchymal stem cell therapy (Nanjing University)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Donor > Allogeneic
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCardiomyopathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaPending
Originator CompaniesNanjing UniversityThe Affiliated Nanjing Drum Tower Hospital Of Nanjing University Medical School
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe Affiliated Nanjing Drum Tower Hospital Of Nanjing University Medical School
Active IndicationsN/A
Inactive IndicationsCardiomyopathies

Other Information

ATC CodeN/A
Related LinksN/A